This activity is expired and is no longer available for CME credit.


Trending…Dosing, Anatomic Dryness, and Treatment Protocols in Retinal Diseases

Author(s)/Faculty: Sophie J. Bakri, MD; Diana V. Do, MD
Release Date: 10/28/2020Expiration Date: 10/27/2021
Credit Type: CME / ABO MOCNumber of Credits: 0
Content Type: LectureProvider:
The incorporation of intravitreal therapy into treatment protocols for neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR) has led to enhanced visual outcomes. In nAMD, anti–vascular endothelial growth factor (VEGF) therapies have demonstrated significant visual acuity gains, yet lack of patient adherence due to treatment burden can result in suboptimal outcomes. Dosing strategies that elongate the time between injection intervals yet maintain early visual acuity gains are currently evolving. In patients with DR, early intervention with anti-VEGF therapies has demonstrated significant slowing of disease progression and reduction of vision-threatening complications. In this educational activity, experts in the field review injection protocols that have been shown to improve the long-term management of DR and nAMD as well as evaluate how the persistence of retinal fluid post-treatment may influence visual outcomes in patients with retinal diseases.